Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NYXH
NYXH logo

NYXH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nyxoah SA (NYXH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.890
1 Day change
3.58%
52 Week Range
8.640
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nyxoah SA (NYXH) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock is in a bearish technical trend, and the company's financials show significant losses despite revenue growth. Analyst ratings are mixed, with price targets being lowered recently. Additionally, there are no strong proprietary trading signals or positive catalysts to justify immediate action. Holding off for now is the most prudent decision.

Technical Analysis

The stock is in a bearish trend with moving averages indicating downward pressure (SMA_200 > SMA_20 > SMA_5). RSI is neutral at 29.099, and MACD is slightly positive but not strong enough to confirm a reversal. Key support levels are at S1: 3.032 and S2: 2.921, with the pre-market price at 2.98 already below S1, suggesting further downside risk.

Positive Catalysts

  • Revenue growth of 55.77% YoY in Q3

  • Positive MACD histogram indicates slight bullish momentum.

Neutral/Negative Catalysts

  • Pre-market price drop of -3.56%. Significant operating losses of EUR 83.5 million in 2025 and a high cash burn rate. Gross margin decline of -2.31% YoY. Analyst price targets have been consistently lowered in recent updates. Stock trend analysis predicts further declines in the short and medium term.

Financial Performance

In Q3 2025, revenue increased by 55.77% YoY to EUR 1.972 million, but net income remains negative at -EUR 23.58 million, albeit improving by 38.23% YoY. EPS improved to -0.63, up 26% YoY. Gross margin dropped to 60.5%, down -2.31% YoY, indicating challenges in cost management.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Stifel maintains a Buy rating but has lowered the price target from $12 to $10, citing equity raise concerns and moving parts. Baird analyst maintains a Neutral rating with a reduced price target of $4.62 from $5.87, reflecting early-stage U.S. rollout challenges.

Wall Street analysts forecast NYXH stock price to rise
5 Analyst Rating
Wall Street analysts forecast NYXH stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 2.790
sliders
Low
5.82
Averages
10.41
High
13
Current: 2.790
sliders
Low
5.82
Averages
10.41
High
13
Baird
David Rescott
Neutral
downgrade
AI Analysis
2026-03-23
Reason
Baird
David Rescott
Price Target
AI Analysis
2026-03-23
downgrade
Neutral
Reason
Baird analyst David Rescott lowered the firm's price target on Nyxoah to $4.62 from $5.87 and keeps a Neutral rating on the shares. The firm updatedits mdel as its U.S. rollout gains traction but still in its early days.
Stifel
Buy
downgrade
$11 -> $10
2026-03-20
Reason
Stifel
Price Target
$11 -> $10
2026-03-20
downgrade
Buy
Reason
Stifel lowered the firm's price target on Nyxoah to $10 from $11 and keeps a Buy rating on the shares. The firm, which updated its model for "some moving parts, still reflects an equity raise in Q3 on the heels of ACCCESS data being reported.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NYXH
Unlock Now

People Also Watch